Researchers tie some cases of sudden infant death syndrome (SIDS) with a genetic mutation that causes an inability to process milk, leaving the child vulnerable to sudden heart failure. Future studies will explore if a drug called Elamipretide can help reduce cardiac events in children with the mutation.
